CVRdatabase
Menu

Studies&Me A/S

Public limited companyCVR 41600020København KActive

Studies&Me A/S is a public limited company, based in København K, active in computer programming activities, founded in 2020. Net profit fell 72% from 2024 to 2025, ending at DKK 5.2m. Equity fell to DKK 16.1m in 2025. Gross profit is higher than that of 79% of the companies in the industry in the database.

Follow
PDF reportCompare

Key figures · financial year 2025

Gross profitDKK 12.1m−47.5% vs. 2024
Net profitDKK 5.2m−71.9% vs. 2024
EquityDKK 16.1m−40.2% vs. 2024
Employees10latest month from CVR

What has changed

calculated from recorded figures and dates

Financials: 2025 against 2024

  • Gross profit fell 48% (2024 → 2025), to DKK 12.1m.
  • Net profit fell 72% (2024 → 2025), to DKK 5.2m.
  • Equity fell 40% (2024 → 2025), to DKK 16.1m.

Management and owners, last 24 months

  • New in management: Mark Høgh Gandrup (board member, 01/01/2026) and Pierre Khaitrine (chair of the board, 29/07/2026).
  • Stepped down: Karl Sebastian Inger (board member, 29/07/2026) and Jakob Brix Christensen (board member, 01/01/2026).

Registrations, last 24 months

  • 27/02/2025: Moved to Sølvgade 10, 5. tv, 1307 København K

Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.

Financial statements

Financial years 2021–2025 · amounts in DKK thousand

Equity and net profit

−DKK 60m−DKK 40m−DKK 20mDKK 0DKK 20mDKK 40m20212022202320242025
EquityNet profit
Financial figures for Studies&Me A/S
20212022202320242025Change
Revenuenot statednot statednot statednot statednot stated–
Gross profit7,938−18,007−4,24923,10912,130−47.5%
Operating profit (EBIT)−60,841−19,829−6,07517,0426,717−60.6%
Profit before tax−60,833−19,933−5,96217,0066,638−61%
Net profit−56,167−17,096−4,65118,4415,178−71.9%
Total assets32,36417,60011,57448,58962,430+28.5%
Equity30,21513,1198,46826,90816,086−40.2%
Liabilities2,1494,4813,10621,68146,344+113.8%
Cash and cash equivalents4,1629,81533014,1640−100%
Average number of employees353613710+42.9%

Source: annual reports filed with the Danish Business Authority (XBRL). Figures for the company (not the group); change is the latest year against the year before. “–” means the figure is not stated in the annual report. Revenue is not stated for 2021, 2022, 2023, 2024, 2025: smaller companies may omit it, and we do not derive it from other figures.

Download the figures as CSV · free with an account, amounts in whole DKK

−DKK 20m−DKK 10mDKK 0DKK 10mDKK 20m20212022202320242025
Gross profitMedian, the industry (1,661 companies)

Signals from the financial statements

calculated from the 2025 figures

  • Equity fell sharply

    Equity fell 40% from 2024 to 2025 (DKK 26.9m to DKK 16.1m).

    How is this calculated?

    Equity has fallen by at least 30% from the previous annual report, and it was positive the year before.

The signals are rules applied to the figures in the annual reports. They are not an assessment or credit rating of the company. See Data and method.

Annual reports

5 financial years
Annual reports for Studies&Me A/S
Financial yearPeriodPublishedFigures forDocuments
202501/01/2025 – 31/12/202503/06/2026The companyPDF not statedXBRL
202401/01/2024 – 31/12/202406/05/2025The companyPDFXBRL
202301/01/2023 – 31/12/202315/05/2024The companyPDFXBRL
202201/01/2022 – 31/12/202226/05/2023The companyPDFXBRL
202113/08/2020 – 31/12/202129/04/2022The companyPDFXBRL

The figures from all the annual reports are shown on this page. The documents themselves (PDF and XBRL, the machine-readable edition) are downloaded with a Pro account: sign in or create a free account, and then choose Pro. XBRL is the edition the figures on the page are read from.

Employees

monthly figures from CVR
02468101208/2309/2310/2311/2312/2301/2402/2403/2404/2405/2406/2407/2408/2409/2410/2411/2412/2401/2502/2503/2504/2505/2506/2507/2508/2509/2510/2511/2512/2501/2602/2603/2604/2605/2606/2607/26
Employees

Position in the industry

1,661 companies in the database

Comparison with the other companies in computer programming activities based on the latest financial year.

Gross profitDKK 12.1mNo. 349 of 1,656
Better than 79% of the companies in the industry
EquityDKK 16.1mNo. 196 of 1,661
Better than 88% of the companies in the industry
Number of employees10No. 454 of 1,661
Better than 73% of the companies in the industry

Industry median: gross profit DKK 2.6m, net profit DKK 93,491, equity DKK 1m, 4 employees.

DKK 100kDKK 978kDKK 9.6mDKK 93.7mDKK 428.6mHere
Distribution of gross profit for 1,474 companies in the industry (latest financial year, logarithmic scale). Amber bar: where this company sits.

Compared with similar companies

size, age and company form
Rank among similar companies
GroupGross profitEquity
Companies with fewer than 20 employees69,967 companies in the comparison
No. 3,448of 69,742
Better than 95%
No. 6,684of 69,964
Better than 90%
Same industry and fewer than 20 employees1,365 companies in the comparison
No. 101of 1,363
Better than 93%
No. 60of 1,365
Better than 96%
Companies that are between 5 and 14 years old33,688 companies in the comparison
No. 3,559of 33,588
Better than 89%
No. 2,704of 33,687
Better than 92%
All companies of type A/S18,025 companies in the comparison
No. 8,120of 17,786
Better than 54%
No. 6,963of 18,024
Better than 61%

The rank is calculated among companies in the database with a figure for the latest financial year, and is shown only for groups of at least ten companies.

Compare with the industry

Computer programming activities
Gross profit
  1. Studies&Me A/SDKK 12.1m
  2. Stibo Systems A/SDKK 916.6m
  3. Trackunit ApSDKK 897.1m
Net profit
  1. Studies&Me A/SDKK 5.2m
  2. Stibo Systems A/SDKK 155.9m
  3. Trackunit ApSDKK 206.3m
Equity
  1. Studies&Me A/SDKK 16.1m
  2. Stibo Systems A/SDKK 309.7m
  3. Trackunit ApSDKK 1.7bn
Employees
  1. Studies&Me A/S10
  2. Stibo Systems A/S201
  3. Trackunit ApS249

Latest financial year per company. Choose up to three companies from the largest in the industry.

Owners and group

from the Public Ownership Register
Owners
Studies&Me A/S

Management

5 active registrations

Executive management

Executive management at Studies&Me A/S
NameRoleAppointed
Mette Haugaard SkaksenDirector01/10/2023
Christoffer von Sehested SchousboeDirector01/10/2023

Board of directors

Board of directors at Studies&Me A/S
NameRoleAppointed
Jeppe Ragnar AndersenBoard member02/05/2022
Mark Høgh GandrupBoard member01/01/2026
Pierre KhaitrineChair of the board29/07/2026
Founders
Leo Pharma A/S
Former management (9)
Former management at Studies&Me A/S
NameRoleAppointedResigned
Anders KronborgChair of the board13/08/202002/05/2022
Anne Cathrine FleischerBoard member13/08/202002/05/2022
John Robert ZibertCEO13/08/202010/12/2021
John KrayacichBoard member13/08/202002/05/2022
Anne Cathrine FleischerCEO10/12/202102/05/2022
Henning Heiberg AndersenBoard member02/05/202231/01/2024
Nicolas Clément Tipsmark BouchetCEO02/05/202201/10/2023
Karl Sebastian IngerBoard member02/05/202229/07/2026
Jakob Brix ChristensenBoard member31/01/202401/01/2026

Signing rule: Selskabet tegnes af to bestyrelsesmedlemmer i forening, af et bestyrelsesmedlem og en direktør i forening, eller af den samlede bestyrelse i forening

Address and production units

2 active production units

Sølvgade 10
1307 København K

København Municipality · Postcode 1307

Production units
Production unitAddressEmployeesP number
Studies&Me A/SHauser Plads 20, 1, 1127 København K101026164687
Studies&Me A/SSølvgade 10, 1307 København K41029732988

Purpose

Selskabets formål er drive virksomhed inden for sundhedsydelser samt anden virksomhed, der efter bestyrelsens skøn er forbundet dermed.

The purpose is quoted from the register in Danish.

Changes year by year

35 registered events
20265 changesmanagement 4 · accounts 1
  • Pierre Khaitrine appointed chair of the board
  • Karl Sebastian Inger stepped down as board member
  • Annual report for 2025 published
  • Mark Høgh Gandrup appointed board member
  • Jakob Brix Christensen stepped down as board member
20252 changesaccounts 1 · address 1
  • Annual report for 2024 published
  • Moved to Sølvgade 10, 5. tv, 1307 København K
20243 changesaccounts 1 · management 2
  • Annual report for 2023 published
  • Jakob Brix Christensen appointed board member
  • Henning Heiberg Andersen stepped down as board member
20234 changesmanagement 3 · accounts 1
  • Christoffer von Sehested Schousboe appointed director
  • Mette Haugaard Skaksen appointed director
  • Nicolas Clément Tipsmark Bouchet stepped down as ceo
  • Annual report for 2022 published
202212 changesaddress 1 · management 8 · ownership 2 · accounts 1
  • Moved to Hauser Plads 20, 1, 1127 København K
  • Karl Sebastian Inger appointed board member
  • Henning Heiberg Andersen appointed board member
  • Nicolas Clément Tipsmark Bouchet appointed ceo
  • Jeppe Ragnar Andersen appointed board member
  • Anne Cathrine Fleischer stepped down as ceo
  • Anne Cathrine Fleischer stepped down as board member
  • John Krayacich stepped down as board member
  • Anders Kronborg stepped down as chair of the board
  • Sanos Group ApS registered as owner (100%)
  • LEO PHARMA A/S is no longer registered as owner
  • Annual report for 2021 published
20212 changesmanagement 2
  • Anne Cathrine Fleischer appointed ceo
  • John Robert Zibert stepped down as ceo
20207 changescapital 1 · founded 1 · management 4 · ownership 1
  • Share capital changed from 400,000 DKK to 1,000,000 DKK
  • Registered as Studies&Me A/S
  • Anne Cathrine Fleischer appointed board member
  • John Krayacich appointed board member
  • John Robert Zibert appointed ceo
  • Anders Kronborg appointed chair of the board
  • LEO PHARMA A/S registered as owner (100%)

Related companies

Same industry in København

See all →

Same people in management

Largest in the industry

See all →

Source and updates

The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 24/10/2026. The company is protected against advertising; contact details are not shown, and the data must not be used for marketing.

View in CVRReport a correction